Close Menu

NEW YORK – Bionano Genomics reported after the close of the market on Thursday a 31 percent year-over-year decrease in its fourth quarter revenues.

The San Diego-based genome mapping firm reported $2.8 million in Q4 revenue, down from $4.0 million a year ago. Revenues consisted of $1.5 million in instrument revenue, down 50 percent from Q4 2018 and consumables revenue of $1.1 million, up 35 percent from the prior year period.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.